KCM
JAZZ icon

Kornitzer Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Kornitzer Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18,600
Closed -$2.31M – 491
2023
Q2 		$2.31M Sell
18,600
-425
-2% -$57.2K 0.05% 317
2023
Q1 		$2.78M Hold
19,025
– – 0.06% 290
2022
Q4 		$3.03M Hold
19,025
– – 0.06% 288
2022
Q3 		$2.54M Hold
19,025
– – 0.05% 299
2022
Q2 		$2.97M Sell
19,025
-10
-0.1% -$1.54K 0.06% 293
2022
Q1 		$2.96M Sell
19,035
-5,955
-24% -$864K 0.05% 312
2021
Q4 		$3.18M Sell
24,990
-85
-0.3% -$11.2K 0.05% 321
2021
Q3 		$3.27M Sell
25,075
-1,450
-5% -$219K 0.05% 306
2021
Q2 		$4.71M Buy
26,525
+7,425
+39% +$1.29M 0.07% 279
2021
Q1 		$3.14M Buy
19,100
+500
+3% +$82.3K 0.05% 301
2020
Q4 		$3.07M Buy
+18,600
New +$2.77M 0.05% 303
2020
Q2 		– Sell
-5,304
Closed -$529K – 509
2020
Q1 		$529K Sell
5,304
-3,476
-40% -$449K 0.01% 437
2019
Q4 		$1.31M Sell
8,780
-8,180
-48% -$1.11M 0.02% 381
2019
Q3 		$2.17M Sell
16,960
-18,195
-52% -$2.44M 0.04% 328
2019
Q2 		$5.01M Buy
35,155
+17,777
+102% +$2.39M 0.09% 251
2019
Q1 		$2.48M Hold
17,378
– – 0.04% 300
2018
Q4 		$2.15M Buy
17,378
+85
+0.5% +$12.6K 0.04% 305
2018
Q3 		$2.91M Hold
17,293
– – 0.05% 288
2018
Q2 		$2.98M Buy
+17,293
New +$2.83M 0.05% 281

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Kornitzer Capital Management's JAZZ Position: Q3 2023 in Review

Kornitzer Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2023, closing a stake of 18,600 shares — an estimated $2.31M sold.

Kornitzer Capital Management first reported a position in JAZZ in Q2 2018 and held it in 19 quarters. The position peaked at $5.01M in Q2 2019. 484 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

  • Kornitzer Capital Management reported no remaining Jazz Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Kornitzer Capital Management sold 18,600 Jazz Pharmaceuticals shares in Q3 2023, an estimated $2.31M.
  • Kornitzer Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and held it in 19 quarters.
  • Kornitzer Capital Management's Jazz Pharmaceuticals position peaked at $5.01M in Q2 2019.
  • 484 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on Kornitzer Capital Management's 13F filing for Q3 2023, filed 31 Oct 2023.